109766 ⎘
dsDNA viruses; Details; Herpesviridae Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
HERPESVIRUS COMPOSITIONS AND RELATED METHODS
#2Larygotracheitis Virus (LT) Vector Vaccines for use with Avian Respiratory Pathogens
#3REPLICATION-COMPETENT CONTROLLED ALPHA-HERPESVIRUS VECTORS AND USES THEREFORE
#4SELF-ASSEMBLING PROTEIN NANOPARTICLES WITH BUILT-IN SIX-HELIX BUNDLE PROTEINS
#5ALUMINUM NANOCRYSTAL DELIVERY SYSTEM, AND SELF-ASSEMBLED PARTICLE ADJUVANT VACCINE BASED ON BINDING OF ALUMINUM NANOCRYSTAL DELIVERY SYSTEM AND VACCINE ANTIGEN MOLECULE
#6RECOMBINANT HERPESVIRUS OF TURKEY VECTORS EXPRESSING ANTIGENS OF AVIAN PATHOGENS AND USES THEREOF
#7VIRUS
#8VACCINE COMPOSITIONS OF HERPESVIRUS ENVELOPE PROTEIN COMBINATIONS TO INDUCE IMMUNE RESPONSE
#9MODULATED IMMUNODOMINANCE THERAPY
#10CANCER VACCINE AND METHOD OF USE THEREOF
#11RECOMBINANT HVT AND USES THEREOF
#12HSV-2-delta-gD vaccines and methods for their production and use
#13RECOMBINANT HERPESVIRUS OF TURKEYS (HVT) AND PREPARATION METHOD AND USE THEREOF
#14MULTIVALENT HVT VECTOR VACCINE
#15Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof
#16VACCINES FOR TREATING SARS INFECTIONS IN CANCER PATIENTS
#17COMPOSITIONS, COMPRISING IMPROVED IL-12 GENETIC CONSTRUCTS AND VACCINES, IMMUNOTHERAPEUTICS AND METHODS OF USING THE SAME
#18Herpesvirus compositions and related methods
#19VACCINATION USING HERPESVIRUS GENOMES IN NUCLEIC ACID FORM
#20Combination Of Local And Systemic Immunomodulative Therapies For Enhanced Treatment of Cancer
#21Cell Line for Production of Marek's Disease Virus Vaccine and Methods of Making and Using the Same
#22Epstein-Barr virus-like particles with broadened antigenic spectrum
#23HSV-2-DELTA-gD VACCINES AND METHODS FOR THEIR PRODUCTION AND USE
#24Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof
#25VACCINE COMPOSITIONS OF HERPESVIRUS ENVELOPE PROTEIN COMBINATIONS TO INDUCE IMMUNE RESPONSE
#26Liquid vaccines of live enveloped viruses
#27Method of producing a designer blood product, method of using a designer blood product, and diet for selectively enhancing blood profile
#28Non-neuroinvasive viruses and uses thereof
#29Non-neuroinvasive viruses and uses thereof
#30Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer
#31Compositions and methods for enhancing innate immunity in a subject for treatment of infections and cancer and other acute and chronic conditions of the eye
#32Immunization agents and methods of use
#33SELF-ASSEMBLING PROTEIN NANOPARTICLES WITH BUILT-IN SIX-HELIX BUNDLE PROTEINS
#34Vaccine compositions of herpesvirus envelope protein combinations to induce immune response
#35Virus
#36Monoclonal Antibodies to B Virus And Their Use For Identification Of B Virus Specific Reactive Peptides
#37Compositions and methods for generating reversion free attenuated and/or replication incompetent vaccine vectors
#38Truncated glycoprotein G of herpes simplex virus 2
#39Feline calicivirus vaccine
#40Compositions, comprising improved IL-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same
#41Immortalised chicken embryo fibroblasts
#42Cytokine
#43Thermostable vaccines based on ether lipids and native viral envelope proteins
#44Promoters
#45Combination of local rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer
#46Non-neuroinvasive viruses and uses thereof
#47RECOMBINANT SELF-REPLICATING POLYCISTRONIC RNA MOLECULES
#48Immunization agents and methods of use
#49Compositions and methods for enhanced innate immunity
#50Vaccine in the form of a recombinant sero type 9 avian adenovirus vector
#51THERAPEUTIC COMPOSITIOJNS AND METHODS FOR INDUCING AN IMMUNE RESPONSE TO HERPES SIMPLEX VIRUS TYPE 2 (HSV-2)
#52Modulated immunodominance therapy
#53Immunogenic composition
#54Infectious laryngotracheitis virus (ILTV) vaccine using recombinant newcastle disease virus vector
#55West Nile Virus vaccine
#56MODULATED IMMUNODOMINANCE THERAPY
#57HERPES SIMPLEX VIRUS VACCINES
#58Koi herpesvirus vaccine
#59T cell expansion
#60Stimulation of neonatal immunity against EHV-1
#61Live attenuated infectious laryngotracheitis virus (ILTV) vaccines and preparation thereof
#62Compositions, comprising improved Il-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same
#63Cyprinid herpesvirus II-sensitive brain tissue cell line of and establishing method and use thereof
#64Conditionally replication deficient herpes virus and use thereof in vaccines
#65CROSS-PROTECTION OF BOVINES AGAINST B. trehalosi INFECTION BY A MULTI-VALENT VACCINE
#66Combination of local and systemic immunomodulative therapies for melanoma and liver cancer
#67Combination of rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer
#68Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein C and uses thereof
#69Cytokine
#70Herpesvirus compositions and related methods
#71Method of producing a designer blood product, method of using a designer blood product, and diet for selectively enhancing blood profile
#72Compositions, comprising improved IL-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same
#73METHOD OF TREATING PREGNANT COWS AND/OR HEIFERS
#74KOI HERPESVIRUS VACCINE
#75Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
#76Herpes simplex virus vaccines
#77Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
#78HSV-1 epitopes and methods for using same
#79ORAL VACCINES PRODUCED AND ADMINISTERED USING EDIBLE MICRO-ORGANISMS INCLUDING LACTIC ACID BACTERIAL STRAINS
#80Herpes simplex virus vaccines
#81Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer
#82ORAL VACCINES PRODUCED AND ADMINISTERED USING EDIBLE MICRO-ORGANISM
#83RECOMBINANT KOI HERPESVIRUS (KHV) OR CYPRINID HERPESVIRUS 3 (CYHV-3) AND A VACCINE FOR THE PREVENTION OF A DISEASE CAUSED BY KHV/CYHV-3 IN CYPRINUS CARPIO CARPIO OR CYPRINUS CARPIO KOI
#84West Nile Virus vaccine
#85Cytokine
#86HSV-1 epitopes and methods for using same
#87Method of treating pregnant cows and/or heifers
#88Recombinant infectious laryngotracheitis virus and uses thereof
#89Mutant HSV, materials and methods for generation of mutant HSV
#90DNA vaccine for Koi herpes virus (KHV) disease
#91Recombinant infectious laryngotracheitis virus and uses thereof
#92Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic FHV-1 infections, and preventing or treating conjunctivitis
#93Recombinant herpesvirus and uses thereof
#94Equine herpesvirus vaccine
#95Probiotic enterococci for improved immunity
#96Stabilizers for veterinary vaccines
#97Method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral DNA
#98Trivalent vaccine with maternal anitbody transfer via the milk
#99Recombinant infectious laryngotracheitis virus and uses thereof
#100Immunizing fish against viral infection
#101Equine herpesvirus vaccine